Clinical Trial Update: SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SIR-Spheres 90Y resin microspheres for liver metastases from uveal melanoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• SIR-Spheres 90Y microspheres (Yttrium-90 resin microspheres)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Stage IV Uveal Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2025-11-14